Your browser doesn't support javascript.
loading
A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood-Brain Barrier Permeability and Targets Glioblastoma.
Cho, Choi-Fong; Farquhar, Charlotte E; Fadzen, Colin M; Scott, Benjamin; Zhuang, Pei; von Spreckelsen, Niklas; Loas, Andrei; Hartrampf, Nina; Pentelute, Bradley L; Lawler, Sean E.
Afiliação
  • Cho CF; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Farquhar CE; Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA.
  • Fadzen CM; Harvard Stem Cell Institute, Harvard University, Boston, MA 02115, USA.
  • Scott B; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Zhuang P; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • von Spreckelsen N; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Loas A; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Hartrampf N; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Pentelute BL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Lawler SE; Department of General Neurosurgery, Centre of Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50937 Cologne, Germany.
Cancers (Basel) ; 14(9)2022 Apr 28.
Article em En | MEDLINE | ID: mdl-35565337

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article